Pharma pursued safe haven for its CME spend last year
Drug firms increased their continuing medical education (CME) grant activity last year, a sign of faith in what has been a heavily scrutinized area.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.